GUFIC BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 4.50 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹691 Cr | ₹779 Cr | ₹488 Cr | ₹379 Cr | ₹351 Cr |
| Expenses | ₹556 Cr | ₹631 Cr | ₹404 Cr | ₹327 Cr | ₹305 Cr |
| Operating Profit (Excl OI) | ₹135 Cr | ₹148 Cr | ₹84 Cr | ₹52 Cr | ₹46 Cr |
| Other Income | ₹2.57 Cr | ₹3.10 Cr | ₹3.73 Cr | ₹5.79 Cr | ₹4.17 Cr |
| Interest | ₹8.22 Cr | ₹5.37 Cr | ₹14 Cr | ₹14 Cr | ₹10 Cr |
| Depreciation | ₹22 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr | ₹4.65 Cr |
| Profit Before Tax | ₹107 Cr | ₹127 Cr | ₹58 Cr | ₹30 Cr | ₹35 Cr |
| Profit After Tax | ₹80 Cr | ₹96 Cr | ₹44 Cr | ₹23 Cr | ₹22 Cr |
| Earnings Per Share (Rs) | ₹8.59 | ₹8.22 | ₹9.89 | ₹4.56 | ₹2.34 |
| PAT Margin (%) | 9.16 | 9.95 | 11.30 | 8.53 | 5.80 |
| ROE(%) | 19.57 | 25.84 | 43.31 | 29.22 | 22.17 |
| ROCE(%) | 17.37 | 23.23 | 47.29 | 30.05 | 21.01 |
| Total Debt/Equity(x) | 0.60 | 0.90 | 0.23 | 0.32 | 0.90 |
Key Financials |
||
| Market Cap | : | ₹ 4,043.6 Cr |
| Revenue (TTM) | : | ₹ 803.8 Cr |
| Net Profit(TTM) | : | ₹ 84.9 Cr |
| EPS (TTM) | : | ₹ 8.5 |
| P/E (TTM) | : | 47.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GUFIC BIOSCIENCES | -9.7% | -7.2% | 37.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -4.7% | 48.8% |
| CIPLA | -0.9% | -1.7% | 17.3% |
| DR REDDYS LABORATORIES | -1% | -8.9% | 6.5% |
| ZYDUS LIFESCIENCES | -1% | -4% | 48.4% |
| DIVIS LABORATORIES | 4.4% | 3.1% | 66% |
| MANKIND PHARMA | -2.1% | -0.6% | 33.1% |
| TORRENT PHARMACEUTICALS | 2.2% | -5% | 49.1% |
| LUPIN | 2.8% | -2.9% | 70.8% |
GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | -11.36 % |
| 5 Yr CAGR | 18.46 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹691 Cr | -11.36 | |
| Mar2023 | ₹779 Cr | 59.76 | |
| Mar2022 | ₹488 Cr | 28.74 | |
| Mar2021 | ₹379 Cr | 8.00 | |
| Mar2020 | ₹351 Cr | - | |
GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | -9.04 % |
| 5 Yr CAGR | 30.81 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹135 Cr | -9.04 | |
| Mar2023 | ₹148 Cr | 76.39 | |
| Mar2022 | ₹84 Cr | 61.03 | |
| Mar2021 | ₹52 Cr | 13.33 | |
| Mar2020 | ₹46 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.63 % |
| 5 Yr CAGR | 10.44 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 19.5% | 2.63 | |
| Mar2023 | 19% | 10.40 | |
| Mar2022 | 17.21% | 25.07 | |
| Mar2021 | 13.76% | 4.96 | |
| Mar2020 | 13.11% | - | |
GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | -16.84 % |
| 5 Yr CAGR | 38.06 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹80 Cr | -16.84 | |
| Mar2023 | ₹96 Cr | 116.68 | |
| Mar2022 | ₹44 Cr | 94.96 | |
| Mar2021 | ₹23 Cr | 3.40 | |
| Mar2020 | ₹22 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -7.94 % |
| 5 Yr CAGR | 12.10 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 9.16 % | -7.94 | |
| Mar2023 | 9.95 % | -11.95 | |
| Mar2022 | 11.3 % | 32.47 | |
| Mar2021 | 8.53 % | 47.07 | |
| Mar2020 | 5.8 % | - | |
GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 4.50 % |
| 5 Yr CAGR | 38.42 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹8.59 | 4.50 | |
| Mar2023 | ₹8.22 | -16.89 | |
| Mar2022 | ₹9.89 | 116.89 | |
| Mar2021 | ₹4.56 | 94.87 | |
| Mar2020 | ₹2.34 | - | |
GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | -25.23 % |
| 5 Yr CAGR | -4.65 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 17.37% | -25.23 | |
| Mar2023 | 23.23% | -50.88 | |
| Mar2022 | 47.29% | 57.37 | |
| Mar2021 | 30.05% | 43.03 | |
| Mar2020 | 21.01% | - | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹403.2 |
| Current MarketCap | : | ₹ 4,043.6 Cr |
| Updated EOD on | : | Nov 22,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -9.7% |
-7.2% |
37.4% |
| SENSEX | 1.8% |
-2.5% |
19.9% |
GUFIC BIOSCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MIDSMALLCAP | 1.7% | -5% | 34.3% |
| S&P BSE SMALL CAP | 1.3% | -5.5% | 33.4% |
| S&P BSE HEALTHCARE | 1.3% | -2% | 47% |
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
No NSE index found
You may also like the below Video Courses
FAQ about GUFIC BIOSCIENCES Financials
How the annual revenues of GUFIC BIOSCIENCES have changed ?
The Revenues of GUFIC BIOSCIENCES have decreased by -11.36% YoY .
How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 4.50 % YoY .
Check out Intrinsic Value of Peers of GUFIC BIOSCIENCES
Compare Stock Analytics of Peers of GUFIC BIOSCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
